Literature DB >> 20383509

Whole-body MRI in the childhood form of hypophosphatasia.

C Beck1, H Morbach, C Wirth, M Beer, H J Girschick.   

Abstract

Hypophosphatasia (HPP) is a rare inborn error of bone metabolism caused by various defects in the gene coding for the tissue-nonspecific alkaline phosphatase (TNSAP). It results in a reduced activity of the TNSAP and elevated concentrations of its substrates, including inorganic pyrophosphate. Clinical features of HPP include defective bone mineralisation with bone deformities, fractures and chronic non-bacterial osteomyelitis. Renal damage due to calcification, craniosynostosis and dental abnormalities with premature loss of dentition are further complications. Until now, detailed descriptions of whole-body magnetic resonance imaging (WB-MRI) in HPP do not exist. Here, we analysed WB-MRIs of 4 children with the childhood form of HPP. Deformities and defects of the long bones could be seen. All patients showed radiological lesions in the metaphyses of the long bones predominantly in the lower extremities being consistent with hyperaemia and oedema. Differential diagnosis includes an inflammatory process being active in these locations.

Entities:  

Mesh:

Year:  2010        PMID: 20383509     DOI: 10.1007/s00296-010-1493-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  18 in total

1.  Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia.

Authors:  Michael P Whyte; Deborah Wenkert; William H McAlister; M Zulf Mughal; Anthony J Freemont; Richard Whitehouse; Eileen M Baildam; Stephen P Coburn; Lawrence M Ryan; Steven Mumm
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

2.  TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation.

Authors:  Ru Liu-Bryan; Kenneth Pritzker; Gary S Firestein; Robert Terkeltaub
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

Review 3.  [Hypophosphatasia].

Authors:  C Beck; H Morbach; M Stenzel; P Schneider; H Collmann; G Girschick; H J Girschick
Journal:  Klin Padiatr       Date:  2009-07-23       Impact factor: 1.349

4.  Treatment of childhood hypophosphatasia with nonsteroidal antiinflammatory drugs.

Authors:  H J Girschick; H W Seyberth; H I Huppertz
Journal:  Bone       Date:  1999-11       Impact factor: 4.398

5.  Cryopyrin activates the inflammasome in response to toxins and ATP.

Authors:  Sanjeev Mariathasan; David S Weiss; Kim Newton; Jacqueline McBride; Karen O'Rourke; Meron Roose-Girma; Wyne P Lee; Yvette Weinrauch; Denise M Monack; Vishva M Dixit
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

6.  Chronic non-bacterial osteomyelitis in children.

Authors:  H J Girschick; P Raab; S Surbaum; A Trusen; S Kirschner; P Schneider; T Papadopoulos; H K Müller-Hermelink; P E Lipsky
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

7.  Neurosurgical aspects of childhood hypophosphatasia.

Authors:  H Collmann; E Mornet; S Gattenlöhner; C Beck; H Girschick
Journal:  Childs Nerv Syst       Date:  2008-09-04       Impact factor: 1.475

Review 8.  Whole-body MRI in children: current status and future applications.

Authors:  Kassa Darge; Diego Jaramillo; Marilyn J Siegel
Journal:  Eur J Radiol       Date:  2008-09-16       Impact factor: 3.528

9.  Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia.

Authors:  H J Girschick; P Schneider; I Haubitz; O Hiort; H Collmann; M Beer; Y S Shin; H W Seyberth
Journal:  Orphanet J Rare Dis       Date:  2006-06-28       Impact factor: 4.123

10.  Chronic multifocal non-bacterial osteomyelitis in hypophosphatasia mimicking malignancy.

Authors:  Hermann J Girschick; Etienne Mornet; Meinrad Beer; Monika Warmuth-Metz; Peter Schneider
Journal:  BMC Pediatr       Date:  2007-01-23       Impact factor: 2.125

View more
  16 in total

Review 1.  Hypophosphatasia.

Authors:  Agnès Linglart; Martin Biosse-Duplan
Journal:  Curr Osteoporos Rep       Date:  2016-06       Impact factor: 5.096

2.  Clinical, radiographic and biochemical characteristics of adult hypophosphatasia.

Authors:  T Schmidt; H Mussawy; T Rolvien; T Hawellek; J Hubert; W Rüther; M Amling; F Barvencik
Journal:  Osteoporos Int       Date:  2017-05-25       Impact factor: 4.507

Review 3.  Chronic recurrent multifocal osteomyelitis.

Authors:  Patrícia Costa-Reis; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2013-05-22       Impact factor: 8.317

Review 4.  Hypophosphatasia: an overview of the disease and its treatment.

Authors:  M L Bianchi
Journal:  Osteoporos Int       Date:  2015-08-06       Impact factor: 4.507

5.  Tissue-nonspecific alkaline phosphatase is an anti-inflammatory nucleotidase.

Authors:  L Bessueille; A Briolay; J Como; S Mebarek; C Mansouri; M Gleizes; A El Jamal; R Buchet; C Dumontet; E L Matera; E Mornet; J L Millan; C Fonta; D Magne
Journal:  Bone       Date:  2020-02-04       Impact factor: 4.398

6.  Update: Cytokine Dysregulation in Chronic Nonbacterial Osteomyelitis (CNO).

Authors:  Sigrun R Hofmann; Angela Roesen-Wolff; Gabriele Hahn; Christian M Hedrich
Journal:  Int J Rheumatol       Date:  2012-05-21

Review 7.  Whole-Body MRI in Children: Current Imaging Techniques and Clinical Applications.

Authors:  Hyun Woo Goo
Journal:  Korean J Radiol       Date:  2015-08-21       Impact factor: 3.500

8.  Healthcare resource utilization in the management of hypophosphatasia in three patients displaying a spectrum of manifestations.

Authors:  Anjali B Daniel; Vrinda Saraff; Nick J Shaw; Robert Yates; M Zulf Mughal; Raja Padidela
Journal:  Orphanet J Rare Dis       Date:  2018-08-16       Impact factor: 4.123

9.  Frequency and age at occurrence of clinical manifestations of disease in patients with hypophosphatasia: a systematic literature review.

Authors:  Shelagh M Szabo; Ioannis C Tomazos; Anna Petryk; Lauren C Powell; Bonnie M K Donato; Yuri A Zarate; Anatoly Tiulpakov; Gabriel Ángel Martos-Moreno
Journal:  Orphanet J Rare Dis       Date:  2019-04-25       Impact factor: 4.123

Review 10.  Multiple Functions of MSCA-1/TNAP in Adult Mesenchymal Progenitor/Stromal Cells.

Authors:  David Estève; Jean Galitzky; Anne Bouloumié; Caroline Fonta; René Buchet; David Magne
Journal:  Stem Cells Int       Date:  2015-12-29       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.